MedPacto Inc Ordinary Shares 235980
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- KRW 8,420.00–8,600.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 8,460.00 / KRW 8,490.00
- Market Cap
- KRW 284.09 Bil
- Volume/Avg
- 687 / 843,263
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
MedPacto Inc is a drug discovery and development company based in South Korea. It is engaged in developing anticancer drugs and medicines which focuses on therapeutics targeting cancer and autoimmune diseases. Its products are in pipeline.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 62
- Website
- http://www.medpacto.com
Comparables
Valuation
|
Metric
|
235980
|
310210
|
323990
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 4.66 | 7.42 | 4.91 |
Price/Sales | — | 805.74 | — |
Price/Cash Flow | — | — | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
235980
|
310210
|
323990
|
|---|---|---|---|
Quick Ratio | — | — | — |
Current Ratio | 8.27 | 4.69 | 29.60 |
Interest Coverage | −71.41 | −18.54 | −260.75 |
Quick Ratio
235980
310210
323990
Profitability
|
Metric
|
235980
|
310210
|
323990
|
|---|---|---|---|
Return on Assets (Normalized) | −67.25% | −42.78% | −29.47% |
Return on Equity (Normalized) | −125.25% | −96.10% | −30.90% |
Return on Invested Capital (Normalized) | −76.72% | −44.97% | −33.70% |
Return on Assets
235980
310210
323990
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Hvfkhjpqqm | Pkmn | $586.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Kxzxnxcg | Jmgycl | $115.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Jbnykwjj | Jqxqyt | $108.2 Bil | |
MRNA
| Moderna Inc | Ysbktsgg | Xlrnd | $54.0 Bil | |
ARGX
| argenx SE ADR | Rlxqvypgg | Lpzd | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Jydfpgtvb | Jmgd | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Vsvqwprs | Ccjzdf | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Npccntjc | Lqbmsm | $14.6 Bil | |
INCY
| Incyte Corp | Tprxshl | Jvhpmy | $12.9 Bil | |
RPRX
| Royalty Pharma PLC Class A | Pslmhtgnjx | Lkmqcdf | $12.3 Bil |